Massive malaria study aims to unlock secrets of infection in mothers and kids
NCT ID NCT01168271
First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 4 times
Summary
This large observational study in Mali is following up to 15,000 pregnant women and children to understand why some get malaria and others don't. Researchers are looking at immune responses, parasite features, and other factors that influence infection and disease severity. The goal is to gather knowledge that could speed up the development of better vaccines and treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify key immune and parasite factors that guide the development of more effective malaria vaccines for mothers and children.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly provide a cure or therapy. Results may take years to translate into practical interventions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 15,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2010
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant women presenting for antenatal consultations and delivery and their newborns; children aged 0-3 years in Ouelessebougou and Febrile children ages 0-10 years hospitalized and non-hospitalized in Ouelessebougou or the Pediatric service of Gabriel Toure Hospital in Bamako; Re-enrollees who were originally enrolled at birth and completed the Pregnant Women and Newborn Cohort
- Ages
-
1 day to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: A study participant must satisfy the following criteria to be or have been enrolled in this study: 1. Pregnant women aged 15-45 years and their newborn infants who are residents of the district of Ouelessebougou for at least one year at the time of enrollment (cohort completed clinical follow up; sample and data analysis ongoing); OR 2. Children who previously participated in the 1st cohort of "pregnant women and their newborn infants", OR 3. Children aged 3 years or less, who are residents of the district of Ouelessebougou for at least one year at the time of enrollment (cohort completed clinical follow up; sample and data analysis ongoing), OR 4. Febrile hospitalized children (aged 0-10 years), including those with positive and negative blood smears for P. falciparum in Ouelessebougou or the pediatric service of Gabriel Toure Hospital in Bamako. Febrile non-hospitalized children (aged 0-10 years) with non-severe malaria will be recruited at outpatient clinics in Ouelessebougou district health hospital and nearby facilities, with no chronic or serious illness. 5. Pregnant women aged 15-25 in Ouelessebougou district health centers or maternity unit of Gabriel Toure Hospital in Bamako and for a case-control study of pregnancy malaria and preeclampsia. Cases include women with signs/symptoms of preeclampsia. Control pregnant women without signs/symptoms of preeclampsia will be recruited sequentially after identification of individual cases, matched for parity, age (+/-2 years) and pregnancy trimester.(cohort completed clinical follow up; sample and data analysis ongoing) 6. The study participant or parent/guardian understands the study and gives informed consent for participation of themselves and/or their child, and agrees to have samples stored. EXCLUSION CRITERIA: A participant will be excluded from the study if any one or more of the following criteria are met: 1. Chronic, debilitating illness, other than malaria, determined by history and physical examination of mother or study participant. 2. Conditions that in the judgment of the investigator could increase the risk to the volunteer. 3. History of previous participation in a malaria vaccine trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Malaria are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Gabriel Toure Hospital
RECRUITINGBamako, Mali
-
Ouelessebougou Clinical Research Center
RECRUITINGWolossébougou, Mali
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Finger-Prick blood test reveal hidden malaria in the placenta?
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Can a fetal heart ultrasound index predict trouble in High-Risk pregnancies?
- A bracelet and a blood pressure cuff: a simple plan to protect new mothers at risk
- Can scheduled malaria drugs shield infants from severe illness?
- Can a simple preventive drug cut malaria and anemia in infants?